BIONANOSMART_DDS

Biopolymer-Based Nanoparticle “Smart” Drug Delivery Systems and their Biopharmaceutical Application by Oral Administration

 Coordinatore UNIVERSIDADE DE SANTIAGO DE COMPOSTELA 

 Organization address address: "PAZO DE SAN XEROME, PRAZA DO OBRADOIRO S/N"
city: SANTIAGO DE COMPOSTELA
postcode: 15782

contact info
Titolo: Dr.
Nome: Fernando
Cognome: Sedano Arnaez
Email: send email
Telefono: +34 981 547050
Fax: +34 981 528019

 Nazionalità Coordinatore Spain [ES]
 Totale costo 216˙049 €
 EC contributo 216˙049 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2007-4-2-IIF
 Funding Scheme MC-IIF
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-10-01   -   2010-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

 Organization address address: "PAZO DE SAN XEROME, PRAZA DO OBRADOIRO S/N"
city: SANTIAGO DE COMPOSTELA
postcode: 15782

contact info
Titolo: Dr.
Nome: Fernando
Cognome: Sedano Arnaez
Email: send email
Telefono: +34 981 547050
Fax: +34 981 528019

ES (SANTIAGO DE COMPOSTELA) coordinator 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

ph    surface    cell    biopharmaceutical    rat    model    techniques    scattering    sensitivity    temperature    administration    oral    modifying    therapeutic    performance    balance    nanoparticle    nanoparticles   

 Obiettivo del progetto (Objective)

'This initiative aims to gain both fundamental understanding and applied knowledge on novel polysaccharide-based nanoparticles to be utilized as ‘smart’ advanced delivery systems of therapeutic biomacromolecules for oral administration. To this end, nanoparticles will be harnessed from chitosan and other polyionic polysaccharides of biomedical use, cross-linked with a natural non-toxic biocompatible agent. Sensitivity to changes in temperature and pH will be conferred by modifying the surface charge (zeta potential) by modifying the local hydrophilic/hydrophobic balance the nanoparticle surface. While sensitivity towards two biomolecules of therapeutic significance will be achieved by modifying the nanoparticle surface by molecular imprinting, using a non-covalent approach. Phase transitions in these systems will be investigated by means of biophysical techniques including dynamic light scattering and SAXS (small-angle X-ray scattering). The adsorption capacity and selectivity of the molecularly imprinted surface will be studied by quartz crystal micro balance with dissipation mode (QCM-D) techniques. The in vitro release profile will be evaluated as a function of the presence of the external stimuli (temperature, pH and concentration of specific molecules). Citotoxicity and cell uptake will be evaluated in Caco-2 cell monoculture and the biopharmaceutical performance will be evaluated for selected prototypes after oral administration in a rat model.the biopharmaceutical performance will be evaluated after oral administration in a rat model.'

Altri progetti dello stesso programma (FP7-PEOPLE)

AAPLQIC (2013)

Light-phonon quantum interface with atomic arrays in a cavity

Read More  

USEFUL (2014)

USEFUL SUPERCONVERGENCE EXTRACTION FOR FILTERING OF UNDERRESOLVED SOLUTIONS

Read More  

OPENLABCAMPUS (2013)

Neglected Diseases Tres Cantos Open Lab Campus

Read More